|Demographic and baseline characteristics of patients and HCPs|
|Median age, year (SD)||44.6 (15.1)|
|National patient organization member, %||10|
|Single, no partner||25|
|Single, with partner||26|
|Chronic back pain||15|
|Currently receiving UC therapy, %||76|
|Mean qualification year (SD)||1992 (9.1)|
|Lower GI/IBD specialist, %||68|
|Teaching hospital, %||67|
|Mean % of working day devoted to clinical practice (SD)||87.4 (11.2)|
|Mean number of patients with UC seen in typical month, n (SD)||35.2 (33.0)|
|Mean year of qualification (SD)||1992 (7.5)|
|Mean year becoming IBD Nurse (SD)||2003 (3.8)|
|Clinical nurse specialist||84|
|Teaching hospital, %||80|
|Mean % of working day devoted to direct patient care (SD)||80.8 (14.1)|
|Mean number of patients with UC seen in typical month, n (SD)||66.6 (40.2)|
|Percentage of nurses who make treatment decisions for patients with UC||86|
|Percentage of nurses who are qualified nurse prescriber||44|
|Percentage of nurses who write 5-ASA prescriptions for mild-to-moderate UC||77|
|Mean number of 5-ASA prescriptions written per month (SD)||21.4 (15.9)|
HCP, healthcare professional; SD, standard deviation; UC, ulcerative colitis; 5-ASA, 5-aminosalicylic acid; GI, gastrointestinal; IBD, inflammatory bowel disease.
*All patients currently taking prescription medication for their UC.
†Immunomodulator or immunosuppressant.
Schreiber et al.
Schreiber et al. BMC Gastroenterology 2012 12:108 doi:10.1186/1471-230X-12-108